Tandem Diabetes Care, Inc. (TNDM)
21.70
-0.80
(-3.56%)
USD |
NASDAQ |
Jan 09, 16:00
21.70
0.00 (0.00%)
After-Hours: 20:00
Tandem Diabetes Care Research and Development Expense (Annual): 184.17M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Insulet Corp. | 219.60M |
| Intuitive Surgical, Inc. | 1.145B |
| Integra LifeSciences Holdings Corp. | 54.43M |
| Merit Medical Systems, Inc. | 87.47M |
| iRhythm Technologies, Inc. | 71.46M |